OpGen

OpGen Debt Growth

The Year-over-Year Debt Growth of OpGen (OPGN) as of Oct 19, 2026 is -12.10 %. In the previous year, Year-over-Year Debt Growth was -41.07 % — a change of -70.54% (higher).

Debt Growth

-12.10 %

YoY

-70.54%

Last updated:

Year-over-Year Debt Growth of OpGen is 2023 -12.10 % . Year-over-Year Debt Growth of OpGen was 2022 -41.07 % . It decreases by -70.54% higher compared to the previous year.

The OpGen Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2016
-16.87 USD
Jan 1, 2017
-4.34 USD
Jan 1, 2018
46.26 USD
Jan 1, 2019
150.94 USD
Jan 1, 2020
380.36 USD
Jan 1, 2021
10.20 USD
Jan 1, 2022
-41.07 USD
Jan 1, 2023
-12.10 USD
The OpGen Debt Growth history
YEARDebt GrowthYoY
-12.10 %-70.54%
-41.07 %-502.50%
10.20 %-97.32%
380.36 %+152.00%
150.94 %+226.28%
46.26 %-1,165.78%
-4.34 %-74.27%
-16.87 %-66.05%
-49.69 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Year-over-Year Debt Growth of OpGen is -12.10 % in 2023.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth OpGen since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's OpGen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — OpGen

All Key Metrics — OpGen